RT Journal Article T1 Enhanced susceptibility of galectin-1 deficient mice to experimental colitis A1 Fernández Pérez, Raquel A1 López Santalla, Mercedes A1 Sánchez Domínguez, Rebeca A1 Alberquilla, Omaira A1 Gutiérrez Cañas, Irene A1 Juarranz Moratilla, Yasmina A1 Bueren, Juan A. A1 Garin, Marina I. AB Galectin-1 is aβ-galactoside-binding lectin, ubiquitously expressed in stromal, epithelial, and different subsets of immune cells. Galectin-1 is the prototype member of the galectin family which shares specificity withβ-galactoside containing proteins and lipids. Immunomodulatory functions have been ascribed to endogenous galectin-1 due to its induction of T cell apoptosis, inhibitory effects of neutrophils and T cell trafficking. Several studies have demonstrated that administration of recombinant galectin-1 suppressed experimental colitis by modulating adaptive immune responses altering the fate and phenotype of T cells. However, the role of endogenous galectin-1 in intestinal inflammation is poorly defined. In the present study, the well-characterized acute dextran sulfate sodium (DSS)-induced model of ulcerative colitis was used to study the function of endogenous galectin-1 during the development of intestinal inflammation. We found that galectin-1 deficient mice (Lgals1−/−mice) displayed a more severe intestinal inflammation, characterized by significantly elevated clinical scores, than their wild type counterparts. The mechanisms underlying the enhanced inflammatory response in coliticLgals1−/−mice involved an altered Th17/Th1 profile of effector CD4+T cells. Furthermore, increased frequencies of Foxp3+CD4+regulatory T cells in colon lamina propria inLgals1−/−mice were found. Strikingly, the exacerbated intestinal inflammatory response observed inLgals1/mice was alleviated by adoptive transfer of wild type Foxp3+CD4+regulatory T cells at induction of colitis. Altogether, these data highlight the importance of endogenous galectin-1 as a novel determinant in regulating T cell reactivity during the development of intestinal inflammation. PB Frontiers Media YR 2021 FD 2021-06-28 LK https://hdl.handle.net/20.500.14352/106065 UL https://hdl.handle.net/20.500.14352/106065 LA eng NO Fernandez-Perez R, Lopez-Santalla M, Sánchez-Domínguez R, Alberquilla O, Gutiérrez-Cañas I, Juarranz Y, Bueren JA and Garin MI (2021) Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis. Front. Immunol. 12:687443. NO Este trabajo fue subvencionado por el Instituto de Salud Carlos III y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) NO Ministerio de Ciencia, Innovación y Universidades (España) NO European Commission DS Docta Complutense RD 3 ago 2025